Yilmaz Mahshid becomes CEO of Medivir

Monday 7 September 2020
Medivir AB
Appointee name
Yilmaz Mahshid


Yilmaz Mahshid is to join the Swedish biotech company Medivir AB as chief executive officer, replacing Uli Hacksell, who will stay on the board of directors. Dr Mahshid was previously chief financial officer at PledPharma AB and before that, investment manager at the venture capital company Industrifonden. He has a PhD in medical biochemistry and biophysics from the Karolinska Institute in Sweden where he began his career as a researcher.
Medivir announced the appointment on 18 August 2020
Copyright 2020 Evernow Publishing Ltd